Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus

Journal of Obstetrics and Gynaecology

Volumn 25, Issue 6, 2005, Pages 579-582

  Kelekci, S ^a,b   Yilmaz, B ^a   Savan, K ^a   Sonmez, S ^a  

^a Suleymaniye Maternity Hospital   (Turkey)

^b Sakarya Mahallesi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGE DISTRIBUTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; HEALTH CENTER; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MACROSOMIA; NORMAL HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PREGNANCY DIABETES MELLITUS; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST;

CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; GLUCOSE INTOLERANCE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 31944450342     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610500231518     Document Type: Article

References (11)

1. Aberg A, Rydhstroem H, Frid A. 2001. Impaired glucose tolerance associated with adverse pregnancy outcome: A population-based study in southern Sweden. American Journal of Obstetrics and Gynecology 184:77-83.
2. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. 1998. Vascular permeability in experimental diabetes is associated with reduced endothelial occluding content: vascular endothelial growth factor decreased occluding in retinal endothelial cells. Penn State retina research Group. Diabetes 47:1953-1959.
3. Bartha JL, Wood J, Kyle PM, Soothill PW. 2003. The effect of metabolic control on fetal nuchal translucency in women with insulin-dependent diabetes: a preliminary study. Ultrasound in Obstetrics and Gynecology 21:451-454.
4. Brausewetter F, Jehle PM, Jung MF, Boehm BO, Brueckel J, Hombach V et al. 2001. Micro vascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF I) and vascular endothelial growth factor (VEGF). Hormone and Metabolic Research 33:713-720.
5. Fukada Y, Yasumizu T, Takizawa M, Amemiya A, Hoshi K. 1998. The prognosis of fetuses with transient nuchal translucency in the first and early second trimester. Acta Obstetricia et Gynecologica Scandinavica 76:913-916.
6. Haak MC, Van Vugt JMG. 2003. Pathophysiology of increased nuchal translucency: a review of the literature. Human Reproduction 9:175-184.
7. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039.
8. Nicolaides KH, Heath V, Cicero S. 2002. Increased fetal nuchal translucency at 11-14 weeks. Prenatal Diagnosis 22:308-315.
9. Plante GE, Chakir M, Ettaouil K, Lehoux S, Sirosis G. 1996. Consequences of alteration in capillary permeability. Canadian Journal of Physiology and Pharmacology 74:824-833.
10. Snijder RJM, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 351:243-346.
11. Vambergue A, Nuttens MC, Verier-Mine O, Dognin C, Capoen JP, Fontaine P. 2000. Is mild gestational hyperglycemia associated with maternal and neonatal complications? The Digest Study. Diabetic Medicine 17:203-208.